Results 31 to 40 of about 9,288,830 (350)
PURPOSE Many patients with HR+, HER2− early breast cancer (EBC) will not experience recurrence or have distant recurrence with currently available standard therapies.
S. Johnston +28 more
semanticscholar +1 more source
Purpose: Ribociclib plus endocrine therapy (ET) demonstrated a statistically significant progression-free survival and overall survival (OS) benefit in the phase III MONALEESA-7 trial of pre-/perimenopausal patients with hormone receptor (HR)-positive ...
Yen-Shen Lu +27 more
semanticscholar +1 more source
The research progress of endocrine therapy combined with targeted therapy for triple-positive breast cancer [PDF]
Triple-positive breast cancer (TPBC) refers to breast cancer with positive expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (HER2), accounting for 5%-10% of all pathological types of breast cancer.
Xiaoshan CAO, Binbin CONG
doaj +2 more sources
The growing availability of more effective therapies has contributed to an increased survival of patients with breast cancer. In hormone receptor-positive early disease, increased survival is strongly correlated with the use of adjuvant endocrine therapy,
M. Franzoi +7 more
semanticscholar +1 more source
. Increasing numbers of targeted drugs are used in hormone receptor (HR)-positive metastatic breast cancer (MBC) to overcome or delay resistance to endocrine therapy.
Li Bian +3 more
doaj +1 more source
A hard pill to swallow: a qualitative study of women’s experiences of adjuvant endocrine therapy for breast cancer [PDF]
Objective: To explore women’s experiences of taking adjuvant endocrine therapy as a treatment for breast cancer and how their beliefs about the purpose of the medication, side effects experienced and interactions with health professionals might influence
McCowan, Colin +17 more
core +1 more source
The link between ovarian hormones and breast cancer began to be formed as early as 1882 when TW Nunn observed the spontaneous regression of breast cancer in a woman 6 months after her menstruation ceased [1]. Oophorectomy was first proposed by the German clinician, Schinzinger, on the basis of his observation that younger women had more aggressive ...
Howell, Sacha J.; id_orcid 0000-0001-8141-6515 +1 more
openaire +4 more sources
Endocrine aspects of cancer gene therapy [PDF]
The field of cancer gene therapy is in continuous expansion, and technology is quickly moving ahead as far as gene targeting and regulation of gene expression are concerned.
BOSCARO, MARCO +5 more
core +1 more source
Simple Summary Breast cancer is the leading cause of cancer-related deaths in the female population, with estrogen receptor (ER)-positive breast cancer accounting for two-third of incidents. Endocrine therapy has proven beneficial in treating ER-positive
A. Kawiak, A. Kostecka
semanticscholar +1 more source
Perceptions of Endocrine Therapy in African-American Breast Cancer Survivors: Mixed Methods Study
BackgroundAlthough the incidence of breast cancer is lower in African-American women than in White women, African-American women have a decreased survival rate.
Donevant, Sara +5 more
doaj +1 more source

